Home
Sites

Channels

Choose a channel

Check out the different Progress in Mind content channels.

Select country

Schizophrenia

Are relapse prevention and functioning sufficiently prioritized in the treatment of schizophrenia?

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References

1. Emsley R et al. Schizophr Res 2013;148:117-121

2. Kane JM. J Clin Psychiatry 2007;68 suppl 14:27-30

3. Robinson D et al. Arch Gen Psychiatry 1999;56:241-247

4. Lieberman JA et al. Biol Psychiatry 2001;50:884-897

5. Hegelstad WT et al. Am J Psychiatry 2012;169:374-380

6. Crumlish N et al. Br J Psychiatry 2009;194:18-24

7. Correll C et al. JAMA Psychiatry 2018;75:555-565

8. Andreasen NC et al. Am J Psychiatry 2013;170:609-615 

9. Leucht S et al. Lancet 2012;379(9831):2063–2071

10. Tiihonen J et al. Am J Psychiatry 2011; 168:603-609  

11. Kishimoto T et al. J Clin Psychiatry 2013;74:957-965

12. Weiden PJ et al. J Cin Psychiatry 2015;76:684-690

13. Kane JM et al. J Clin Psychiatry 2019;23;80(3). pii: 18m12546

14. Gorwood et al. Ann Gen Psychiatry 2013;12:8

15. Priebe S et al. Psychother Psychosom 2015;84:304-313

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
Not located in Brazil?
Go to a different regional HUB
Continue to Progress in MindContinue to Progress in Mind BrazilContinue to Progress in Mind SpainContinue to Progress in Mind ItalyContinue to Progress in Mind
You are leaving Progress in Mind
Continue to
Cancel
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Accept
Decline
Congress
Register for access to Progress in Mind in your country
Cancel
New member registration